Abstract Metal oxide nanoparticles have been suggested as good candidates for the development of antibacterial agents. Cerium oxide (CeO 2 ) and iron oxide (Fe 2 O 3 ) nanoparticles have been utilized in a number of biomedical applications. Here, the antibacterial activity of CeO 2 and Fe 2 O 3 nanoparticles were evaluated on a panel of gram positive and gram negative bacteria in both the planktonic and biofilm cultures. Additionally, the effect of combining CeO 2 and Fe 2 O 3 nanoparticles with the broad spectrum antibiotic ciprofloxacin on tested bacteria was investigated. Thus, minimum inhibitory concentrations (MICs) of CeO 2 and Fe 2 O 3 nanoparticles that are required to inhibit bacterial planktonic growth and bacterial biofilm, were evaluated, and were compared to the MICs of the broad spectrum antibiotic ciprofloxacin alone or in the presence of CeO 2 and Fe 2 O 3 nanoparticles. Results of this study show that both CeO 2 and Fe 2 O 3 nanoparticles fail to inhibit bacterial growth and biofilm biomass for all the bacterial strains tested. Moreover, adding CeO 2 or Fe 2 O 3 nanoparticles to the broad spectrum antibiotic ciprofloxacin almost abolished its antibacterial activity. Results of this study suggest that CeO 2 and Fe 2 O 3 nanoparticles are not good candidates as antibacterial agents, and they could interfere with the activity of important antibiotics.
Introduction
The introduction of antimicrobial agents had a vital role in decreasing the total deaths from infectious diseases during the mid-twentieth century (Cohen 2000) . However, the emergence of bacterial resistance to antibacterial drugs has become a serious problem for public health (Kurek et al. 2011) . Many traditionally used antibiotics are not effective anymore in managing drug-resistant bacteria. This might lead to the re-emergence of once controlled microbial diseases (Cohen 2000) . Additionally, many bacteria escape most antibiotic treatments and host defense systems by forming a protective matrix of exopolymeric substances called biofilm (Subbiahdoss et al. 2012; Weir et al. 2008) . Moreover, the horizontal gene transfer between bacteria within biofilms can increase the spread of antibiotic resistance (Fux et al. 2005; Weir et al. 2008 ). Adding to the antibiotic resistance problem is the decline in the development of new antibacterial agents, with only few newly approved agents introduced to the pharmaceutical market (Donadio et al. 2010) . Therefore, there is a great need to develop new antibacterial agents.
Over the last decade, many researchers have been evaluating potential antibacterial effect of metals in their nanoparticle form. Metals including zinc, silver, and copper have been used as antibacterial agents for long time (Subbiahdoss et al. 2012) . The advantage of using metals in their nanoparticle form is that these particles can be prepared to have very small diameter, and therefore to have a high surface area to volume ratio. It is thought that the high surface area to volume ratios and the resultant unique chemico-physical properties of the nanoparticles could contribute to their antimicrobial activities (Huh and Kwon 2011; Pal et al. 2007 ). Moreover, antibacterial nanoparticles influence several structures and biological pathways found in a wide range of pathogenic bacteria. This makes it harder for bacteria to develop resistance against nanoparticles (Nel et al. 2009; Huang et al. 2008; Pal et al. 2007 ).
Cerium oxide (CeO 2 ) nanoparticles are metal oxide nanoparticles that have been exploited in a number of biomedical applications. For example, they have been used as a UV light absorber in sunscreens (Wu et al. 2010) . CeO 2 nanoparticles exhibit an antioxidant activity at physiological pH, and were shown to protect cells against oxidative stress, inflammation, or damage caused by radiation (Tarnuzzer et al. 2005; Niu et al. 2007; Perez et al. 2008) . Studies on the antibacterial activity of CeO 2 nanoparticles have shown mixed results as well. While some studies have suggested antibacterial activity for CeO 2 nanoparticles (Shah et al. 2012) , others have indicated no toxic effect of CeO 2 nanoparticles on bacteria (Negahdary et al. 2012; Pelletier et al. 2010; Thill et al. 2006) .
Iron Oxide nanoparticles represent another nanoparticle that has been utilized in biomedical research due to its biocompatibility, ease to functionalize for many applications, and magnetic characteristics (Gupta and Gupta 2005) . Clinical and experimental applications of iron oxide nanoparticles include its usage in magnetic resonance imaging (MRI) as a contrast agent (Babes et al. 1999) , magnetic fluid hyperthermia (Khandhar et al. 2012; Gonzales-Weimuller et al. 2009 ), targeted drug therapy as a drug carrier (Chertok et al. 2008) , immunoassays, detoxification of biological fluids, tissue repair, and cell separation (Gupta and Gupta 2005; Pareta et al. 2008) . Previous studies have suggested the antibacterial activity of iron oxide nanoparticles in the form of Fe 3 O 4 against some bacteria including Staphylococcus aureus and Staphylococcus epidermidis (Taylor and Webster 2009; Tran et al. 2010) . A study by Ravikumar et al., reported antibacterial effect for Fe 3 O 4 nanoparticles against Pseudomonas aeruginosa, Klebsiella pneumoniae and Streptococcus pyogenes, but had no effect on Escherichia coli, Streptococcus viridans, Acinetobacter sp. and other Klebsiella sp. (Ravikumar et al. 2011) . A recent study by Gokulakrishnan et al. investigated the antibacterial activity of Fe 2 O 3 nanoparticles on a number of bacteria in their planktonic forms (Gokulakrishnan et al. 2012) . In the present study, antibacterial activity of CeO 2 and Fe 2 O 3 nanoparticles on a larger panel of gram-positive and gram-negative bacteria in both the planktonic and biofilm cultures were evaluated. Moreover, the effect of combining CeO 2 and Fe 2 O 3 nanoparticles with the broad spectrum antibiotic ciprofloxacin on tested bacteria was investigated. Aljarrah et al. (2012) . Briefly, equimolar amounts (0.1 M) of Ce(NO 3 ) 3 .6H 2 O and FeCl 3 Á6H 2 O (Sigma Aldrich, St. Louis, MO, USA, [99 %) were added into a two separate 100 ml glass flasks containing 50 ml of 0.2 M glycine (Sigma Aldrich, 99 %). Each solution was rigorously mixed to generate a 0.1 M Fe3? and 0.1 M Ce4? solutions and were, then, transferred into two separate 100 ml Teflon-lined stainless steel vessels. The vessels were tightly sealed and heated to 150°C for 10 h. They were, then, slowly cooled to room temperature. Precipitated powders were washed several times using deionized water and absolute ethanol. The precipitates were sonicated for 5 min prior to filtering, annealed at 250°C in oxygen for 2 h, cooled to room temperature, and dried in air for 10 h.
Materials and methods

Bacterial strains and maintenance
The morphology and the microstructure of samples was observed using field emission scanning electron microscope (FE-SEM, JEOL, Peabody, MA, USA). The crystal structure of the samples was measured using an X-ray diffractometer (XRD, Shimadzu 6000, Kyoto, Japan) with CuKa (k = 1.5418 Å ) radiation in the 2h range of 20-70°. The scan rate was 5°/min.
Biofilm formation and screening
Bacterial biofilms were prepared as described previously (Masadeh et al. 2013; Cernohorska and Votava 2008) . Briefly, 100 ll of bacterial suspension from each of the bacterial strains tested were cultivated in polypropylene tubes containing 2 ml of Trypticase Soy Broth (TSB) supplemented with 1 % glucose for 48 h at 37°C. Culture media was refreshed after 24 h of incubation. In order to screen for biofilm formation, some of the cultivated tubes were stained as described previously (Christensen et al. 1985) . Briefly, after being emptied from their content, culture tubes were stained with trypan blue or safranin. Biofilms were judged by the appearance of a visible film that lined the walls of the tube. Observations were carried out by three independent observers. Biofilms were scored as absent (score 0), weak (score 1), moderate (score 2), or strong (score 3).The average scores were used.
Minimum inhibitory concentration (MIC)
The MICs of the broad spectrum antibiotic ciprofloxacin, CeO 2 nanoparticles, Fe 2 O 3 nanoparticles, ciprofloxacin mixed with CeO 2 nanoparticles, and ciprofloxacin mixed with Fe 2 O 3 nanoparticles were evaluated. MICs were determined using broth macrodilution method according to the Clinical and Laboratory Standards Institute guidelines (Clinical and Laboratory Standards Institute (CLSI) 2012). Aliquots of 10 ll from each bacterial strain tested were inoculated in 10 ml of Muller-Hinton Broth (MHB), and incubated for 24 h at 37°C. After 24 h, bacterial suspensions from each bacterial strain tested were adjusted to 0.5 McFarland (1.5 9 10 8 colony forming units (CFU)/ml).
Five different samples were performed in aqueous solution: bacterial suspension, ciprofloxacin suspension, CeO 2 nanoparticles suspension, Fe 2 O 3 nanoparticles suspension, ciprofloxacin mixed with CeO 2 nanoparticles, and ciprofloxacin mixed with Fe 2 O 3 nanoparticles. Nanoparticles samples were sonicated for 1 h to get a well-dispersed and clear suspension. All samples were incubated for 1 h at 37°C with gentle shaking every 15 min prior to biofilm cultures. Adjusted bacterial suspensions (100 ll) were added to ciprofloxacin, CeO 2 nanoparticles, Fe 2 O 3 nanoparticles, ciprofloxacin mixed with CeO 2 nanoparticles, and ciprofloxacin mixed with Fe 2 O 3 nanoparticles. Bacterial suspensions were incubated at 37°C for 24 h for planktonic cultures, and for 48 h for biofilm cultures as described above. To determine the MIC of ciprofloxacin treatment, the same amount of adjusted bacterial suspension (0.5 McFarland) from each examined bacterial strain were added to serial dilutions of ciprofloxacin. Ciprofloxacin concentrations from 0.015 to 0.96 lg/ml were tested. To determine the MIC of CeO 2 and Fe 2 O 3 nanoparticles treatment, adjusted bacterial suspension (0.5 McFarland) from each examined bacterial strain, were added to twofold serial dilutions of CeO 2 and Fe 2 O 3 nanoparticles. CeO 2 and Fe 2 O 3 nanoparticles concentrations from 8.25 to 528 lg/ml were tested. Similarly, to determine the MIC of ciprofloxacin in the presence of CeO 2 or Fe 2 O 3 nanoparticles adjusted bacterial suspension (0.5 McFarland) from each examined bacterial strain were added to serial dilutions of ciprofloxacin that contains either CeO 2 or Fe 2 O 3 nanoparticles. MICs were determined as the lowest concentration of ciprofloxacin or nanoparticles at which there was no growth, a faint haze or fewer than 3 discrete colonies. Tubes of bacterial suspensions without nanoparticles served as control. As a particle control, tubes of CeO 2 or Fe 2 O 3 nanoparticles solutions were added to tubes containing only MHB at the same concentrations that were used above. Plates were read in triplicate and the higher MIC value was recorded (Clinical and Laboratory Standards Institute (CLSI) 2012).
Statistical analysis
Analysis was performed using GraphPad Prism software (version 4.0, GraphPad software, La Jolla, CA, USA). One-way ANOVA followed by Dunnett's posttest were used to determine significant difference. P values \0.05 was considered significant. (Fig. 1b) indicates the presence of spherical-shaped nanoparticles. The grain boundaries are clean and round with no presence of other phases or salts in microstructure. The mean size of the particles varies from 40 to 50 nm. Figure 2a , b shows the XRD and SEM data for the CeO 2 nanoparticles, respectively. Similarly, XRD peaks show quite high degree of crystallinity of the nanoparticles. No traces of other phases have been detected in the pattern. The SEM shows the presence of spherical-shaped CeO 2 nanoparticles of homogeneous morphology with a grain size from 25 to 50 nm. However, traces of salt washing residues with smaller nanoparticle size are present between the grains and on the grain boundaries of CeO 2 nanoparticles.
Results
Nanoparticles synthesis and characterization
It has been noticed that the pH values of the colloidal solutions plays an important role in the precipitation process and was controlled before and after the hydrothermal process. However, in many cases (especially for the Fe colloidal solution), it is not easy to precipitate specific iron oxide particles directly in the desired size and shape. The size and shape of the nanoparticles can be tailored with relative success by adjusting pH, ionic strength, temperature, nature of the salts (chlorides, sulfates, and nitrates), or the Fe2?/ Fe3? concentration ratio (Issa et al. 2013) . Moreover, based on the careful handling of the hydrothermal process carried out in the current study, we believe that final annealing in oxygen for resultant iron oxide powder facilitates oxidation of Fe 3 O 4 to c-Fe 2 O 3 and produce a monodisperse, porous and magnetic cFe 2 O 3 nanoparticles. This was supported by the X-ray and the SEM data shown in Figs. 1 One way of bacteria to resist aggressive antibiotic treatment and protect themselves against the host immune system is by forming biofilm. Biofilm is a matrix of exopolymeric substances that is impenetrable by most antibiotics and immune cells (Subbiahdoss et al. 2012) . Metal nanoparticles, including zinc oxide and selenium nanoparticles, have been suggested to possess characteristics that enable them to inhibit bacterial biofilm formation (Applerot et al. 2012; Wang and Webster 2013) . In order to examine the effect of CeO 2 and Fe 2 O 3 nanoparticles on bacterial biofilms biomass, MICs of CeO 2 and Fe 2 O 3 nanoparticles were evaluated on a panel of gram positive and gram negative bacterial biofilms, including antibiotic resistant strains. Bacterial suspensions were added to two-fold serial dilutions of CeO 2 and Fe 2 O 3 nanoparticles, and suspensions were incubated for 48 h at 37°C. Bacterial biofilm formation of nanoparticles treated bacteria was compared with biofilm formation in untreated bacterial suspensions. CeO 2 and Fe 2 O 3 nanoparticles showed no antibacterial effect on biofilm biomass of all tested bacterial strains ( Table 2 ). The MICs of ciprofloxacin were used as control and showed significant inhibitory effect on biofilm biomass of all tested bacterial strains ( Fig. 1 a XRD 
Discussion
Metal oxide nanoparticles have been suggested as an important candidate for tackling the healthcare problem of increasing number of antibiotic resistant and biofilm forming bacteria. In this study, two metal oxide nanoparticles, CeO 2 and Fe 2 O 3 nanoparticles, were tested for efficacy as antibacterial agents against a list of gram positive and gram negative bacteria. This list of bacteria included strains that are known to be antibiotic resistant such as MRSA and VRE. Our study has shown that CeO 2 and Fe 2 O 3 nanoparticles failed to inhibit bacterial planktonic growth and biofilm formation as compared to bacterial growth inhibition resulting from ciprofloxacin treatment. Ciproflxacin, however, inhibited the growth of all gram positive and gram negative bacteria tested. A related interesting finding of the current study is that combining CeO 2 or Fe 2 O 3 nanoparticles with ciprofloxacin reduced significantly the antibacterial effect of ciprofloxacin. Ciprofloxacin is a secondgeneration fluoroquinolone antibacterial agent (Drlica and Zhao 1997) . It kills bacteria by inhibiting DNA gyrase, and topoisomerase IV enzymes that are necessary to separate bacterial DNA, therefore, The MIC values for ciprofloxacin alone were significantly (P \ 0. inhibiting cell division (Drlica and Zhao 1997) . It is possible that these nanoparticles interact with ciprofloxacin in a way that prevents its absorption by the bacterial cell. Another possibility is that CeO 2 and Fe 2 O 3 nanoparticles interact directly or indirectly with ciprofloxacin in a way that interferes with ciprofloxacin activity on bacterial DNA inside the bacterial cell. Interestingly, studies have shown that the bioavailability of ciprofloxacin is reduced by 50 % when coadministered with iron compounds (Lode 2001) . Characterization of suggested mechanisms for the interaction of CeO 2 and Fe 2 O 3 nanoparticles with ciprofloxacin is a warranted future study. Studies that evaluated the antibacterial effect of CeO 2 nanoparticles are limited. Some of these studies suggest antibacterial effect for CeO 2 nanoparticles, while other studies show no toxic or inhibitory effect for CeO 2 nanoparticles against bacteria. Thill et al., Pelletier et al., and Kuang et al., have suggested antimicrobial activity of CeO 2 nanoparticles against E. coli, whereas Shah et al., observed that dextran coated CeO 2 nanoparticles are non-lethal to E. coli under various experimental conditions examined (Kuang et al. 2011; Pelletier et al. 2010; Shah et al. 2012; Thill et al. 2006) . Moreover Shah et al., reported that CeO 2 nanoparticles can reduce magnesium and potassium salts antibacterial activity, which is similar to the observation in the current study where CeO 2 nanoparticles almost abolished the antibacterial activity of ciprofloxacin (Shah et al. 2012 ). In addition, CeO 2 nanoparticles have been shown to inhibit Bacillus subtilis, but have no inhibitory effect on Shewanella oneidensis (Pelletier et al. 2010) . These studies utilized different synthesis methods, used CeO 2 nanoparticles of various sizes, and exploited different methods to evaluate CeO 2 nanoparticles antibacterial effect. It has been suggested that a change in the physical and chemical environment can significantly influence nanoparticles bacterial toxicity (Deshpande et al. 2005; Rispoli et al. 2010) .
Although several studies have focused on evaluating the antibacterial effect of nanosized magnetic iron The MIC values for ciprofloxacin alone were significantly (P \ 0. (Ravikumar et al. 2011; Taylor and Webster 2009; Tran et al. 2010) . One study has reported antibacterial activity of Fe 2 O 3 nanoparticles on a number of bacteria in their planktonic forms (Gokulakrishnan et al. 2012) . Another study by He et al., found no inhibitory effect of Fe 2 O 3 nanoparticles on the growth of E. coli. In contrast, the results of the mentioned study suggest an increase in bacterial growth upon Fe 2 O 3 nanoparticles treatment ). In the current study, Fe 2 O 3 nanoparticles showed no inhibitory effect on bacterial growth and biofilm forms of all the bacterial strains tested. In this study, both CeO 2 and Fe 2 O 3 nanoparticles were tested at a wide range of serial twofold concentrations, which is a standard procedure to estimate MIC value for compounds with previously unknown antibacterial activity (Clinical and Laboratory Standards Institute (CLSI) 2012). Future work about the possible antibacterial activity of these nanoparticles should be targeted toward studying concentrations that are above their MIC values.
In conclusion, the current study provides evidence that CeO 2 and Fe 2 O 3 nanoparticles fail to inhibit bacterial planktonic growth and biofilm biomass for all examined gram positive and gram negative bacterial strains. Moreover, CeO 2 and Fe 2 O 3 nanoparticles when combined with the broad sprectrum antibiotic ciprofloxacin almost abolished its inhibitory effect on bacterial growth and biofilm formation. Therefore, this study suggests that CeO 2 and Fe 2 O 3 nanoparticles are not good candidates as antibacterial agents.
